|Articles|September 12, 2016
Takeda Partners With PRA Health Sciences
Takeda Pharmaceuticals has entered into a partnership agreement with PRA Health Sciences.
Advertisement
Takeda Pharmaceuticals has entered into a partnership agreement with PRA Health Sciences. Under this agreement PRA will manage Takeda’s pipeline and marketed products, clinical development and post-approval needs.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA and EMA Align on Ten Principles to Guide Artificial Intelligence Use in Drug Development
2
New Phase II Data Suggest Maternal Nipocalimab Does Not Disrupt Infant Immune Development in Severe HDFN
3
ACT Brief: FDA Capacity Strains Timelines, Sponsors Rethink Site Support, and Regulators Align on AI
4
Clinical Operations Teams Adjust to Evidence and Engagement Gaps
5